Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Martinez-Cuadron D, Serrano J, Gil C, Tormo M, Martinez-Sanchez P, Perez-Simon JA, Garcia-Boyero R, Rodriguez-Medina C, Lopez-Pavia M, Benavente C, Bergua J, Lavilla-Rubira E, Amigo ML, Herrera P, Alonso-Dominguez JM, Bernal T, Colorado M, Sayas MJ, Algarra L, Vidriales MB, Rodriguez-Macias G, Vives S, Perez-Encinas MM, Lopez A, Noriega V, Garcia-Fortes M, Ramos F, Rodriguez-Gutierrez JI, Costilla-Barriga L, Labrador J, Boluda B, Rodriguez-Veiga R, Martinez-Lopez J, Sanz MA, Montesinos P. Evolving treatment patterns and outcomes in older patients (>/=60 years) with AML: changing everything to change nothing? Leukemia. 2021 Jun;35(6):1571-1585. doi: 10.1038/s41375-020-01058-4. Epub 2020 Oct 19. PubMed PMID: 33077867.
AÑO: 2021; IF: 12.883
Jimenez-Fonseca P, Carmona-Bayonas A, Martinez de Castro E, Custodio A, Pericay Pijaume C, Hernandez R, Aguado G, Castro Unanua N, Cano JM, Lopez F, Garrido M, Fernandez Montes A, Visa L, Sanchez Canovas M, Limon ML, Martinez Lago N, Pimentel P, Hurtado A, Azkarate A, Longo F, Diez M, Arias-Martinez A, Sauri T, Martin Carnicero A, Mangas M, Martin Richard M, Granja M, Ramchandani A, Hernandez Perez C, Cerda P, Gil-Negrete A, Calvo M, Vidal Tocino R, Gallego J. External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit? Gastric Cancer. 2021 Mar;24(2):445-456. doi: 10.1007/s10120-020-01116-x. Epub 2020 Sep 24. PubMed PMID: 32970266; PubMed Central PMCID: PMC7902567.
AÑO: 2021; IF: 7.701
Melaiu O, Macauda A, Sainz J, Calvetti D, Facioni MS, Maccari G, Ter Horst R, Netea MG, Li Y, Grzasko N, Moreno V, Jurczyszyn A, Jerez A, Watek M, Varkonyi J, Garcia-Sanz R, Kruszewski M, Dudzinski M, Kadar K, Jacobsen SEH, Mazur G, Andersen V, Rybicka M, Zawirska D, Razny M, Zaucha JM, Ostrovsky O, Iskierka-Jazdzewska E, Reis RM, Stepien A, Beider K, Nagler A, Druzd-Sitek A, Marques H, Martinez-Lopez J, Lesueur F, Avet-Loiseau H, Vangsted AJ, Krawczyk-Kulis M, Butrym A, Jamroziak K, Dumontet C, Vogel U, Rymko M, Pelosini M, Subocz E, Szombath G, Sarasquete ME, Silvestri R, Morani F, Landi S, Campa D, Canzian F, Gemignani F. Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival. Int J Cancer. 2021 Apr 15;148(8):1887-1894. doi: 10.1002/ijc.33377. Epub 2020 Nov 20. PubMed PMID: 33152124.
AÑO: 2021; IF: 7.316
Flores-Funes D, Aguilar-Jimenez J, Martinez-Galvez M, Ibanez-Ibanez MJ, Carrasco-Gonzalez L, Gil-Izquierdo JI, Chaves-Benito MA, Ayala-De La Pena F, Nieto-Olivares A, Aguayo-Albasini JL. Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive results. Surg Oncol. 2021 Sep;38:101636. doi: 10.1016/j.suronc.2021.101636. Epub 2021 Jul 21. PubMed PMID: 34303211.
AÑO: 2021; IF: 2.388
Garcia-Alfonso P, Munoz A, Jimenez-Castro J, Jimenez-Fonseca P, Pericay C, Longo-Munoz F, Reyna-Fortes C, Argiles-Martinez G, Gonzalez-Astorga B, Gomez-Reina MJ, Ruiz-Casado A, Rodriguez-Salas N, Lopez-Lopez R, Carmona-Bayonas A, Conde-Herrero V, Aranda E, On Behalf Of The Ros Study Group. Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study. Cancers (Basel). 2021 Sep 8;13(18):4514. doi: 10.3390/cancers13184514. PubMed PMID: 34572740; PubMed Central PMCID: PMC8468101.
AÑO: 2021; IF: 6.575
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL